Obstetrics

Sickle Cell Disease in Pregnancy

High-Yield Guide

Pharmacology of Obstetrics

Pregnancy in SCD is high-risk. Vaso-occlusive crises, infections, and preeclampsia threaten mother and fetus. Multidisciplinary care is essential.

Pathophysiology

HbS → sickling under hypoxia → vaso-occlusion, hemolysis, ischemia.

Pregnancy ↑ blood volume, CO, hypercoagulability → exacerbates crises.

Maternal Risks

  • Vaso-occlusive crises (most common)
  • Acute chest syndrome
  • Infections (UTI, pneumonia)
  • Anemia, preeclampsia, thromboembolism
Any acute deterioration → rule out crisis, infection, ACS

Fetal Risks

  • IUGR, preterm birth, stillbirth
  • Neonatal complications from prematurity

Antenatal Management

Preconception

  • Genetic counseling
  • Folic acid 5 mg/day
  • Vaccinations

Antenatal

  • Multidisciplinary team
  • Transfusions if severe/recurrent crises
  • Hydration, avoid triggers

Intrapartum & Postpartum

  • Vaginal preferred
  • Epidural, O₂, IV fluids
  • Postpartum: pain control, thromboprophylaxis
  • Crises peak in first 72h

Key Takeaways

  • SCD + pregnancy = high-risk
  • Crises ↑ in pregnancy
  • Folic acid 5 mg/day
  • Serial growth scans
  • Avoid hypoxia, dehydration
  • Multidisciplinary care

Conclusion

SCD in pregnancy requires vigilance, hydration, and teamwork. Early intervention saves lives.

SCD in pregnancy is a tightrope — balance is key.